• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Nuvation Bio Inc. Class A Common Stock (NY: NUVB )

2.680 -0.010 (-0.37%)
Official Closing Price Updated: 7:00 PM EST, Dec 20, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Nuvation Bio Inc. Class A Common Stock

< Previous 1 2 3 4 Next >
Nuvation Bio to Present at the 7th Annual Evercore ISI HealthCONx Conference
November 26, 2024
From Nuvation Bio Inc.
Via Business Wire
Nuvation Bio to Present at the Jefferies London Healthcare Conference
November 12, 2024
From Nuvation Bio Inc.
Via Business Wire
Top 4 Health Care Stocks That May Plunge This Quarter
November 11, 2024
Via Benzinga
Nuvation Bio Reports Third Quarter 2024 Financial Results and Provides Business Update
November 06, 2024
From Nuvation Bio Inc.
Via Business Wire
Fastenal Posts Upbeat Earnings, Joins Wells Fargo, JPMorgan And Other Big Stocks Moving Higher On Friday
October 11, 2024
Via Benzinga
Nuvation Bio Appoints Industry Veteran Philippe Sauvage as Chief Financial Officer
October 07, 2024
From Nuvation Bio Inc.
Via Business Wire
Positive Pooled Data from Nuvation Bio’s TRUST-I and TRUST-II Studies Highlight Taletrectinib’s Best-in-Class Potential for Patients with Advanced ROS1-positive NSCLC, Supporting Planned New Drug Application Submission in the Fourth Quarter of 2024
September 14, 2024
From Nuvation Bio Inc.
Via Business Wire
Why Oracle Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket
September 10, 2024
Via Benzinga
Nuvation Bio to Present at the Cantor Global Healthcare Conference
September 09, 2024
From Nuvation Bio
Via Business Wire
Small-Cap Cancer-Focused Nuvation Bio Pulls Plug On Early-Stage Program After Considering Phase 1 Solid Tumor Data
August 05, 2024
Nuvation Bio halts its NUV-868 BET inhibitor program after Phase 1 study analysis. The decision impacts solid tumor treatments in ovarian, pancreatic, and mCRPC cancers, focusing instead on late-stage... 
Via Benzinga
Nuvation Bio Reports Second Quarter 2024 Financial Results and Provides Business Update
August 05, 2024
From Nuvation Bio Inc.
Via Business Wire
Nuvation Bio Announces Updates and Upcoming Presentations for its ROS1 Inhibitor, Taletrectinib
July 23, 2024
From Nuvation Bio Inc.
Via Business Wire
NeuroBo Pharmaceuticals And 2 Other Penny Stocks Insiders Are Buying
June 26, 2024
Via Benzinga
Nuvation Bio Announces Data from Pivotal Phase 2 TRUST-I Study of its Investigational ROS1 Inhibitor, Taletrectinib, are Published in the Journal of Clinical Oncology and Reported at 2024 ASCO Annual Meeting
June 01, 2024
From Nuvation Bio Inc.
Via Business Wire
Nuvation Bio to Present at the Jefferies Global Healthcare Conference
May 29, 2024
From Nuvation Bio Inc.
Via Business Wire
NUVB Stock Earnings: Nuvation Bio Beats EPS for Q1 2024
May 14, 2024
NUVB stock results show that Nuvation Bio beat analyst estimates for earnings per share the first quarter of 2024. 
Via InvestorPlace
Nuvation Bio Reports First Quarter 2024 Financial Results and Provides Business Update
May 14, 2024
From Nuvation Bio Inc.
Via Business Wire
Nuvation Bio to Present Updated Data on Taletrectinib, a ROS1 inhibitor, at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
April 24, 2024
From Nuvation Bio Inc.
Via Business Wire
Fifth Third Bancorp Reports Upbeat Earnings, Joins Metropolitan Bank Holding, Paramount Global And Other Big Stocks Moving Higher On Friday
April 19, 2024
Via Benzinga
Nuvation Bio Completes Acquisition of AnHeart Therapeutics
April 10, 2024
From Nuvation Bio Inc.
Via Business Wire
ProfoundBio Discovers The Joys Of Having A Wealthy Owner
April 08, 2024
Key Takeaways: Cancer treatment maker ProfoundBio announced it will be purchased by Denmark’s Genmab for $1.8 billion The deal is the fourth acquisition of a China-related innovative drugmaker by a... 
Via Benzinga
Intel, XPeng And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
April 03, 2024
U.S. stock futures were lower this morning, with the Nasdaq futures falling by around 0.2% on Wednesday. 
Via Benzinga
Week In Review: AriBio Sells China Rights To Alzheimer’s Candidate In $770 Million Deal
March 30, 2024
South Korea’s AriBio out-licensed China rights for AR1001, an Alzheimer’s disease candidate, in an agreement worth up to $770 million. The company acquiring the asset asked to remain anonymous because... 
Via Talk Markets
Nuvation Bio Announces Appointment of Colleen Sjogren as Chief Commercial Officer
March 28, 2024
From Nuvation Bio Inc.
Via Business Wire
Why LuxUrban Hotels Shares Are Trading Lower By Around 27%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
March 27, 2024
Shares of LuxUrban Hotels Inc. (NASDAQ: LUXH) fell sharply during Wednesday’s session after the company issued preliminary fourth-quarter revenue outlook below estimates. 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
March 27, 2024
Via Benzinga
Cintas Reports Upbeat Earnings, Joins PaySign, Noah Holdings And Other Big Stocks Moving Higher On Wednesday
March 27, 2024
U.S. stocks were higher, with the Dow Jones index gaining around 300 points on Wednesday. 
Via Benzinga
Topics Stocks
Exposures US Equities
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
March 27, 2024
Via Benzinga
Netflix To Rally Over 15%? Here Are 10 Top Analyst Forecasts For Wednesday
March 27, 2024
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. 
Via Benzinga
Why MariaDB Shares Are Trading Higher By Around 100%; Here Are 20 Stocks Moving Premarket
March 27, 2024
Shares of MariaDB plc (NYSE: MRDB) rose sharply in today’s pre-market trading after Progress Software (NASDAQ: PRGS) announced that it is possibly considering an offer for the company. 
Via Benzinga
< Previous 1 2 3 4 Next >
Site Logo
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap